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Full-thickness skin grafts of the nasal ala
Tan et al. of the Skin Cancer Institute of Tauranga, New Zealand 
describe how various techniques have been used to reconstruct 
surgical defects of the nasal ala. They highlight that a variety of 
ﬂaps have been described for such closures, but go on to men-
tion that full-thickness skin grafts have received little attention 
in the reconstructive literature. The authors present their experi-
ence with full-thickness skin grafts for reconstruction of partial-
thickness defects of the nasal ala in the largest series reported 
to date. They used a retrospective analysis of their Mohs micro-
graphic surgery database over a 9-year period. All cases of full-
thickness skin grafts for reconstruction of the nasal ala were 
identiﬁed. Defect location, size and postoperative complica-
tions were recorded. All patients were reviewed at the time of 
suture removal, and again at 3 and 6 weeks postoperatively 
and longitudinally at 12 months or longer. There were 186 full-
thickness skin grafts of the nasal ala in 181 patients (88 men, 
93 women). The reported age range was 31–88 years with a 
mean of 65 years (median 66 years). The reported defect size 
varied from 0.3 × 0.4 cm to 2.0 × 2.7 cm, with the average 
defect measuring 1.0–1.2 cm in diameter. Thirty-six percent of 
cases (67 of 186) underwent postoperative dermabrasion and 
8% (14 of 186) received postoperative intralesional triamcino-
lone. In no cases was a revision required, and the incidences of 
graft failure and infection were low. Good-to-excellent cosmetic 
results were reported in all patients and postoperative complica-
tions were uncommon and minor. The authors concluded that 
the use of full-thickness skin grafts for defects of the nasal ala 
is a simple and versatile reconstructive option, which (in their 
hands) resulted in excellent functional and aesthetic outcomes. 
Br J Dermatol 2014; 170: 1106–1113.
Delusional infestation in Olmsted 
County, Minnesota
Bailey et al. from the Mayo Clinic set the scene for this study 
by stating that delusional infestation (DI) is a well-recognized 
clinical entity for which there are few reliable epidemiological 
data. They go on to make the case for such a study by stating 
that knowledge of the epidemiology of disease is fundamental 
to an understanding of any disease and its implications. The 
stated aim of this study was to determine the incidence of DI 
using a population-based study. The medical records of Olmsted 
County residents were reviewed using the resources of the 
Rochester Epidemiology Project to conﬁrm each patient’s status 
as a true incident case of DI and to gather demographic infor-
mation. Patients with a ﬁrst-time diagnosis of DI or synonymous 
conditions between 1 January 1976 and 31 December 2010 
were considered incident cases. Of 470 identiﬁed possible 
diagnoses, 64 were true incident cases of DI in this population-
based study. The age- and sex-adjusted incidence was 1.9 [95% 
conﬁdence interval (CI) 1.5–2.4] per 100,000 person-years. The 
mean age at diagnosis was 61.4 years (range 9–92). The inci-
dence of DI increased over the four decades from 1.6 (95% 
CI 0.6–2.6) per 100,000 person-years in 1976–85 to 2.6 (95% 
CI 1.4–3.8) per 100,000 person-years in 2006–10. Bailey et 
al. concluded that the age- and sex-adjusted rate of DI in this 
population-based study was 1.9 per 100,000 person-years. Br J 
Dermatol 2014; 170: 1158–1165.
Epidemiology and comorbidities of 
severe acne in adolescence: a U.S. 
population-based study
Silverberg and Silverberg state that little is known about the 
epidemiology of severe acne in the U.S. They set out to study 
the U.S. prevalence, determinants and comorbidities of severe 
acne in adolescence. They did this by analyzing data from 
the 2007 National Health Interview Survey, a cross-sectional 
questionnaire-based study of 9417 children aged 0–17 years. 
They were then able to determine the prevalence of severe 
acne and its demographics and comorbidities. They report 
that the U.S. prevalence of severe acne was virtually nil in the 
ﬁrst decade of life, but increased in a linear fashion from 11 
years [1.7%, 95% conﬁdence interval (CI) 0.4–3.0%] to 17 
years of age (12.1%, 95% CI 7.8–16.5%; Rao–Scott χ2-test P 
< 0.0001). They report that severe acne was more common in 
white patients than in other racial groups at age 14–15 years 
(P = 0.0004) and in girls at age 11–13 years (P = 0.02). Severe 
acne was associated with a number of comorbid disorders. 
Associated sinopulmonary diseases included sinus infection 
(P = 0.0003), sore throat other than Streptococcus infection 
(P = 0.0003), asthma (P = 0.03) and nonasthmatic lung dis-
ease (P = 0.03). Upper gastrointestinal comorbidities includ-
ed reﬂux/heartburn (P = 0.0003), abdominal pain (P = 0.03), 
nausea/vomiting (P = 0.0001) and food/digestive allergy 
(P = 0.01). Psychological comorbidities included depression 
(P = 0.02), anxiety (P < 0.0001), attention deﬁcit disorder/
attention deﬁcit hyperactivity disorder (P = 0.01) and insom-
nia (P = 0.02). In conclusion, Silverberg and Silverberg report 
that severe acne in the U.S. was more prevalent in older, white 
and female patients, and in those with higher socioeconomic 
status. Br J Dermatol 2014; 170: 1136–1142.
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